NASDAQ · COO · Medical Instruments & Supplies
The Cooper Companies, Inc. (COO) stock analysis
- COO gained 6.7% over the past month versus 0.0% for the S&P 500, ranking 130th of 497 S&P 500 stocks.
- Over 12 months it returned −21.4%, 37.2 points behind the S&P 500, and trades 30.1% below its 52-week high.
- In the last 30 days 0 analysts raised earnings estimates and 16 cut; forward EPS moved 0.0% (−6.2% over 90 days).
- It sits in the Vision & dental segment of the Medtech, Diagnostics & Care, where the 1-month median return is +2.7%.
- The daily chart reads Intermediate downtrend · Decline (since Oct 19, 2026).
One-year price with 50- and 200-day averages
Performance vs the market
Total price return against the S&P 500 (SPY) and the median of US stocks in the same sector.
Chart structure
Read by our daily-bar structure engine from swing highs, swing lows and moving averages.
Holding since Oct 19, 2026
- Price and averages have mixed alignment
- EMA50 fell over the last ten sessions
76 occurrences in 10 years. The median move over the next 20 sessions was +2.8%, positive 67% of the time, against +1.0% for any day in the same period.
Analyst earnings revisions
Changes to the consensus forward-EPS estimate. Rising estimates mean analysts see more profit ahead.
15 analysts cover the stock
Where it sits in the supply chain
Medtech, Diagnostics & Care · Devices, supplies & tests
Contact lenses and clear aligners are largely self-paid, so consumer spending and practice traffic matter more.
Figures are each company's 1-month return; the segment shows its median · Doubler daily batch · company chain maps
Risk profile
Track this stock every day
Hub adds the daily brief, StockFlow factor flow, trade plans and alerts for your watchlist.